Expression of KCNA2 in the dorsal root ganglia of rats with osteoarthritis pain induced by monoiodoacetate.
10.12122/j.issn.1673-4254.2019.05.13
- Author:
Qihong ZHAO
1
;
Qiyou WANG
2
;
Jie XU
3
;
Jiafeng WANG
1
;
Xiaoming DENG
1
Author Information
1. Department of Anesthesiology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai 200433, China.
2. Department of Orthopedics, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
3. Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
- Publication Type:Journal Article
- Keywords:
dorsal root ganglion;
osteoarthritis;
pain;
voltage-gated potassium channel
- MeSH:
Animals;
Disease Models, Animal;
Ganglia, Spinal;
Knee Joint;
Kv1.2 Potassium Channel;
metabolism;
Male;
Osteoarthritis;
complications;
metabolism;
Pain;
etiology;
metabolism;
Promoter Regions, Genetic;
Rats;
Rats, Sprague-Dawley
- From:
Journal of Southern Medical University
2019;39(5):579-585
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the changes in the expression of voltage-gated potassium channel subunit KCNA2 in the dorsal root ganglion (DRG) neurons of rats with osteoarthritis (OA) pain induced by sodium monoiodoacetate and explore the mechanism.
METHODS:A total of 156 adult male Sprague-Dawley rats were randomly divided into blank control group, saline group and intra-articular monoiodoacetate injection-induced OA group. The paw withdrawal mechanical threshold (PWMT) was measured before and at 1, 2, 4, and 6 weeks after monoiodoacetate injection. At 4 weeks after the injection, the pathological changes in the knee joints were analyzed using HE staining and Safranin O-Fast Green staining, and the expression of activating transcription factor 3 (ATF-3) and inducible nitric oxide synthase (iNOS) in the DRG neurons were detected by immunofluorescence staining. The expression of mRNA in the DRG neurons was detected by RT-qPCR at 1, 2, 4 and 6 weeks after the injection. The expression of KCNA2 in the DRG was measured by Western blotting, and the methylation level of promoter region was measured by MSPCR at 4 weeks after the injection.
RESULTS:The PWMT of the rats in OA group was significantly decreased at 2, 4, and 6 weeks after the injection as compared with the baseline ( < 0.05 or < 0.001) as well as the control group ( < 0.05 or < 0.001). Four weeks after the intra-articular injection, fractures and defects on the surface of the articular cartilage, bone hyperplasia, and blurred tidal line were observed in the rats in OA group, but no obvious pathological changes were detected in the control or saline groups. Compared with those in the control group, the expressions of ATF-3 and iNOS were significantly increased ( < 0.01) at 4 weeks after injection; the expression of mRNA at 2, 4 and 6 weeks and the expression of KCNA2 protein at 4 weeks were all significantly decreased ( < 0.05 or < 0.01), and the methylation level of gene was significantly increased at 4 weeks after the injection in OA group ( < 0.01).
CONCLUSIONS:The expression of KCNA2 is decreased in the DRG neurons of rats with OA pain likely as a result of enhanced methylation of promoter region.
